







“Super-Spreaders” and Person-to-Person Transmission of Andes Virus in Argentina
From November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infe...

“Super-Spreaders” and Person-to-Person Transmission of Andes Virus in Argentina
From November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infe...

Statement from the International Hantavirus Society and members of the international hantavirus research and clinical community regarding Andes virus transmission and the current outbreak investigation
This statement summarizes current scientific evidence regarding Andes virus (ANDV) transmission dynamics, including documented person-to-person transmission, outbreak epidemiology, infection control considerations and implications for public health management during the ongoing cruise ship outbreak investigation in the South Atlantic. The document was prepared by members of the International Society for Hantaviruses (ISH) and the international hantavirus scientific and medical community.
Statement from the International Hantavirus Society and members of the international hantavirus research and clinical community regarding Andes virus transmission and the current outbreak investigation
This statement summarizes current scientific evidence regarding Andes virus (ANDV) transmission dynamics, including documented person-to-person transmission, outbreak epidemiology, infection control considerations and implications for public health management during the ongoing cruise ship outbreak investigation in the South Atlantic. The document was prepared by members of the International Society for Hantaviruses (ISH) and the international hantavirus scientific and medical community.
outbreak.info SARS-CoV-2 data explorer
Retracted coronavirus (COVID-19) papers
via CDC We’ve been tracking retractions of papers about COVID-19 as part of our database. Here’s a running list, which will be updated as needed. (For some context on these figures, see…

Correction of scientific literature: Too little, too late!
The Coronavirus Disease 2019 (COVID-19) pandemic has highlighted the limitations of the current scientific publication system, in which serious post-publication concerns are often addressed too slowly to be effective. In this Perspective, we offer suggestions to improve academia’s willingness and ability to correct errors in an appropriate time frame.
Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral
ASAP-0017445 is designed to be a direct-to-generic, globally accessible treatment ready for future coronavirus pandemics.

COVID antihistamine protocol
This current wave of COVID is bad, and I'm seeing a lot of people who were previously NOVID posting photos of their positive tests. I've been trying fairly diligently to get this information out on social media, because I know I follow the literature a lot more closely than a lot of people, so here
#JustPublished! Guidance for the management of passengers linked to the Andes hantavirus outbreak. It provides advice for #PublicHealth professionals managing those potentially exposed to #AndesHantavirus & involved in the 𝗱𝗶𝘀𝗲𝗺𝗯𝗮𝗿𝗸𝗮𝘁𝗶𝗼𝗻, 𝘁𝗿𝗮𝗻𝘀𝗳𝗲𝗿, & 𝗰𝗮𝗿𝗲 𝗼𝗳 𝗽𝗮𝘀𝘀𝗲𝗻𝗴𝗲𝗿𝘀 & 𝗰𝗿𝗲𝘄. bit.ly/4ewVC8G
ECDC publishes guidance for the management of passengers linked to the Andes hantavirus outbreak on cruise ship
bit.lyPart of the rationale for considering all passengers high risk is uncertainty about “close contacts” In this @nejm.org article on Andes strain #hantavirus, 3 people sitting at adjacent tables at a birthday party were infected nejm.org/doi/full/10.1056/NEJMoa200904… (Appendix 1)
LET'S AIR (@nousaerons.bsky.social)

COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season

BMJ Group retracts paper on COVID-19 vaccines and mortality featured in Senate hearing

What to Know About New Covid Vaccines for Fall 2026
Underlying Conditions and the Higher Risk for Severe COVID-19

We were lucky with Hantavirus—next time we might not be

Hantavirus Doesn’t Spread Easily, but Officials May Be Downplaying Risks

Hantavirus-associated cluster of illness on a cruise ship: ECDC assessment and recommendations

The unprecedented and deadly cruise ship hantavirus outbreak, explained

Here’s What You Need to Know About the Hantavirus

Una farmacéutica ya está desarrollando una vacuna contra el hantavirus con tecnología ARN mensajero